APA (7th ed.) Citation

BT, W., T, K., L, W., TJ, M., SE, C., AK, S., . . . BA, K. (2021). Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199. Molecular cancer therapeutics, 20(12), 2483. https://doi.org/10.1158/1535-7163.MCT-20-1132

Chicago Style (17th ed.) Citation

BT, Wang, et al. "Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199." Molecular Cancer Therapeutics 20, no. 12 (2021): 2483. https://doi.org/10.1158/1535-7163.MCT-20-1132.

MLA (9th ed.) Citation

BT, Wang, et al. "Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199." Molecular Cancer Therapeutics, vol. 20, no. 12, 2021, p. 2483, https://doi.org/10.1158/1535-7163.MCT-20-1132.